Jefferies Group’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	$618K	Buy	+30,110	New	+$618K	0.01%	594
2018 Q4	–	Sell	-1,325	Closed	-$111K	–	1749
2018 Q3	$111K	Buy	1,325 +574	+76%	+$48.1K	﹤0.01%	1463
2018 Q2	$72K	Buy	+751	New	+$72K	﹤0.01%	1457